Načítá se...

Phase I trial of docetaxel and thalidomide: a regimen based on metronomic therapeutic principles

PURPOSE: Pre-clinical models have demonstrated the benefit of metronomic schedules of cytotoxic chemotherapy combined with anti-angiogenic compounds. This trial was undertaken to determine the toxicity of a low dose regimen using docetaxel and thalidomide. PATIENTS AND METHODS: Patients with advance...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Sanborn, Sharon L., Cooney, Matthew M., Dowlati, Afshin, Brell, Joanna M., Krishnamurthi, Smitha, Gibbons, Joseph, Bokar, Joseph A., Nock, Charles, Ness, Anne, Remick, Scot C.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2008
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4209291/
https://ncbi.nlm.nih.gov/pubmed/18470481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-008-9137-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!